Gene Editing Market Type, Product, Application and Growth Forecast to 2030 | MRFR

 

Gene Editing Market Overview

 

The Global Gene Editing Market is growing with the rapid pace, mainly due to the technological advancement in the healthcare sector. According to a recent study report published by the Market Research Future, the global market of Gene Editing Market is booming and expected to gain prominence over the forecast period. The gene editing market value is expected to grow at a CAGR (Compound Annual Growth Rate) of about 14.7% to reach USD 19.4 billion over the forecast 2022-2030. 

 

Global Market is driven by the Increased R&D expenditure and growth of biotechnology and pharmaceutical industries, increased funding for genomics research, increasing demand for synthetic genes, global rise in production of genetically modified crops and technological advancements. The restraints of the Gene Editing Market is strict regulatory policies and adverse public perception related to genetic research

 

Gene Editing or Genome editing is a type of genetic engineering where a DNA is inserted, deleted or replaced in the genome of an organism to treat a particular disease. Genes control heredity and provide the basic biological code to determine the specific function of a cell. It is a synthetic modification of chromosomal DNA by using molecular scissors. Cells have a unique mechanism to protect themselves from attack from viruses, fungi and bacteria. Inside each cell lies a group of special proteins, called restriction enzymes. Restriction enzymes cut the DNA of a foreign organism into pieces before it has a chance to damage the cell. These enzymes are just like scissors or termed as molecular scissors.Gene Editing has generated a lot of excitement in academia and drug development. Its promises are two-fold: the unique ability to correct genetic mutations that may cause disease; and its utility in creating and controlling genetic information within patient cells. Emerging science suggests that permanently fixing or “editing” mutated cells, or creating safer and more potent cell-based products with this technology could provide curative, one-time treatments for patients suffering from a broad range of diseases.

 

Market Segmentation

To give the insight information on Global Gene Editing Market report, MRFR has segment the report in to 4 key dynamics –

Segmentation By Methods     : Comprises Crispr, Talen, ZFN, Antisense technology and other.

Segmentation By End-Users   : Comprises biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations (CROs).

Segmentation By Applications: Comprises Plant genetic engineering, cell line engineering, animal genetic engineering, plant genetic engineering and other.

Segmentation By Regions       : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Competitive Analysis:

Gene Editing Market Players are Integrated DNA Technologies, Inc. (U.S.), GenScript USA Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Lonza Group Ltd. (Switzerland), New England Biolabs, Inc. (U.S.), Horizon Discovery Group plc (U.K.), Sangamo Biosciences, Inc. (U.S.), OriGene Technologies, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.)

Regional Analysis

The regional analysis comprises of North America, Europe, Asia Pacific, Middle East and rest of the world. The Gene Editing market is dominated by North America due to the strong growth trend in the pharmaceuticals and biotechnology industries and is followed by Europe. The North American meat industry is among the largest in the world followed by European and Asia Pacific region. The crop and cattle industry forms the largest consumer of genome engineering services in the region, followed by equine, and canine breeding industry.

The Asian region is showing good opportunities in market due to the expansion of leading genome editing companies and increased R&D spending. Emerging economies of Asia Pacific and Latin America are expected to show significant growth in the market due to an increase in the number of laboratories in these regions and development of existing ones for automation of various instrumentation systems. Also, the pharmaceutical industries are also rapidly increasing which is also driving market in Asia region.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Cardiac Monitoring and Cardiac Rhythm Management Device Market Growth Opportunities, Demand and Forecasts, 2020-2027

  Market Highlights The increasing demand for minimally invasive surgeries drives the growth of this market. Advanced technologies in cardiac monitoring and cardiac rhythm management devices have also led to growth in this market.  However, factors such as stringent regulatory approval procedures, the high cost of cardiac devices, and lack of reimbursement policies in developing countries are hindering the growth of the market. Rising prevalence of cardiovascular diseases and the increasing number of unmet medical needs in undeveloped countries are leading to the growth of the  cardiac monitoring and cardiac rhythm management device market . Technical advancements in drug-eluting, MRI compatible pacemakers, and Holter monitors are some of the factors leading to the growth of this market. The growth of the global cardiac monitoring device market is driven by the high prevalence of cardiovascular disorders worldwide. Segmentation The global cardiac monitoring and  card...
Read more

Cancer Biological Therapy Market Demand, Business Strategies, Current Trends And Efficient Techniques, Forecast 2030

  Market Highlights Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors. These various types of biological therapies, which are most of the times stated to biological modifier therapy or immunotherapy, but these types of therapies do not always target cancer cells directly. Further there are other biological therapies like sections of genetic material or antibodies which are commonly known as DNA or RNA, do aim at targeting cancer cells directly. There are also other types of biological therapies that inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies. Cancer Biological therapy market  treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such c...
Read more

Medical Imaging Software Market SWOT Analysis, Dynamics, Drivers, Key Indicators and Forecast to 2022-2030

  Medical Imaging Software Market Highlights Medical imaging software supports processing and producing high-resolution images of the internal body parts of a human for disease diagnosis and treatment. The emergence of 3D and 4D imaging technologies, increasing the prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field are some factors that are anticipated to drive the market growth during the assessment period.  Additionally, a rise in the number of diagnostic centres and increased healthcare expenditure is likely to contribute to market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of equipment related to clinical validation and lack of skilled professionals m...
Read more